EU
Investigators are exploring mechanisms to make data available, while acknowledging that scaling up and sustaining the initiative will take place beyond 2022.
Register and Report Results
Science writes that a new clinical trial registry in Europe may help improve clinical trial results reporting.
Additional Concessions Sought
Reuters reports Illumina could face an anti-trust investigation in Europe tied to its Grail acquisition if it does not offer additional concessions.
Can Take Part
The Guardian writes that the European Commission no longer plans to prevent the UK from participating in certain space and supercomputing projects.
European Union to Review Illumina's Planned Grail Acquisition Under New Guidance
Illumina reaffirmed its commitment to the $8 billion deal and said it does not believe the European authorities have jurisdiction to review it.
Mar 11, 2019
Jan 30, 2019
Sep 27, 2018
Jan 8, 2018
May 10, 2016
May 21, 2015